Joseph Stringer

Stock Analyst at Needham

(0.84)
# 2233
Out of 5,337 analysts
337
Total ratings
31.18%
Success rate
-8.88%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
INZY Inozyme Pharma
Maintains: Buy
15 12
1.32 809.09% 19 May 14, 2025
ANNX Annexon
Maintains: Buy
16 11
1.75 528.57% 19 May 13, 2025
VIR Vir Biotechnology
Maintains: Buy
19 14
4.5 211.11% 17 May 12, 2025
APLS Apellis Pharmaceutic...
Maintains: Buy
40 29
16.68 73.86% 20 May 7, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
66 72
57.3 25.65% 24 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 6 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 55
32.67 68.35% 21 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
3.29 751.06% 51 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
35 35
19.27 81.63% 10 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
28.47 110.75% 17 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
8.96 145.54% 22 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
320 320
267.48 19.64% 21 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
90 90
29.48 205.29% 17 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 10
1.38 624.64% 17 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
17.17 115.49% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
8.42 113.78% 2 Aug 24, 2021